MeiraGTx Holdings plc Increase (Decrease) in Deferred Revenue
MeiraGTx Holdings plc (MGTX) reported Increase (Decrease) in Deferred Revenue of -$50.00 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2026-05-14
- MeiraGTx Holdings plc increase (decrease) in deferred revenue for the quarter ending 2026-03-31 was -$50.00K.
- MeiraGTx Holdings plc increase (decrease) in deferred revenue for the quarter ending 2025-12-31 was -$36.00K, a 101.29% decline year-over-year.
- MeiraGTx Holdings plc increase (decrease) in deferred revenue for the quarter ending 2025-09-30 was $1.02M, a 69.22% decline year-over-year.
- MeiraGTx Holdings plc increase (decrease) in deferred revenue for the quarter ending 2025-06-30 was -$1.39M, a 2343.55% decline year-over-year.
- MeiraGTx Holdings plc increase (decrease) in deferred revenue for fiscal 2025 was -$731.00K, a 102.74% decline from fiscal 2024.
- MeiraGTx Holdings plc increase (decrease) in deferred revenue for fiscal 2024 was $26.66M.
- MeiraGTx Holdings plc increase (decrease) in deferred revenue for fiscal 2023 was -$7.51M.
- MeiraGTx Holdings plc increase (decrease) in deferred revenue for fiscal 2022 was -$15.92M.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 3 month as first filed | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 6 month as first filed | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 9 month as first filed | Increase (Decrease) in Deferred Revenue 12 month | Increase (Decrease) in Deferred Revenue 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | -$50.00K 10-Q · filed 2026-05-14 | -$86.00K derived: sum of 2 quarters · filed 2026-05-14 | $939.00K derived: sum of 3 quarters · filed 2026-05-14 | -$452.00K derived: sum of 4 quarters · filed 2026-05-14 | ||||
| 2025-12-31 | -$36.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $989.00K derived: sum of 2 quarters · filed 2026-03-30 | -$402.00K derived: sum of 3 quarters · filed 2026-03-30 | -$731.00K 10-K · filed 2026-03-30 | ||||
| 2025-09-30 | $1.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$366.00K derived: sum of 2 quarters · filed 2025-11-13 | -$695.00K 10-Q · filed 2025-11-13 | $2.10M derived: sum of 4 quarters · filed 2026-05-14 | ||||
| 2025-06-30 | -$1.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$1.72M 10-Q · filed 2025-08-14 | $1.08M derived: sum of 3 quarters · filed 2026-05-14 | $4.41M derived: sum of 4 quarters · filed 2026-05-14 | ||||
| 2025-03-31 | -$329.00K 10-Q · filed 2026-05-14 | $2.47M derived: sum of 2 quarters · filed 2026-05-14 | $5.80M derived: sum of 3 quarters · filed 2026-05-14 | $5.86M derived: sum of 4 quarters · filed 2026-05-14 | ||||
| 2024-12-31 | $2.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $6.13M derived: sum of 2 quarters · filed 2026-03-30 | $6.19M derived: sum of 3 quarters · filed 2026-03-30 | $26.66M 10-K · filed 2026-03-30 | ||||
| 2024-09-30 | $3.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $3.39M derived: sum of 2 quarters · filed 2025-11-13 | $23.87M 10-Q · filed 2025-11-13 | $28.34M derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | $62.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $20.54M 10-Q · filed 2025-08-14 | $25.01M derived: sum of 3 quarters · filed 2025-08-14 | $19.91M derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | $20.48M 10-Q · filed 2025-05-13 | $24.95M derived: sum of 2 quarters · filed 2025-05-13 | $19.84M derived: sum of 3 quarters · filed 2025-05-13 | $16.30M derived: sum of 4 quarters · filed 2025-05-13 | ||||
| 2023-12-31 | $4.47M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | -$632.00K derived: sum of 2 quarters · filed 2025-03-13 | -$4.17M derived: sum of 3 quarters · filed 2025-03-13 | -$7.51M 10-K · filed 2025-03-13 | ||||
| 2023-09-30 | -$5.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$8.64M derived: sum of 2 quarters · filed 2024-11-13 | -$11.98M 10-Q · filed 2024-11-13 | -$6.69M derived: sum of 4 quarters · filed 2024-11-13 | ||||
| 2023-06-30 | -$3.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | -$6.87M 10-Q · filed 2024-08-12 | -$1.59M derived: sum of 3 quarters · filed 2024-08-12 | -$6.40M derived: sum of 4 quarters · filed 2024-08-12 | ||||
| 2023-03-31 | -$3.33M 10-Q · filed 2024-05-09 | $1.95M derived: sum of 2 quarters · filed 2024-05-09 | -$2.86M derived: sum of 3 quarters · filed 2024-05-09 | -$13.62M derived: sum of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | $5.29M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | $472.00K derived: sum of 2 quarters · filed 2024-03-15 | -$10.29M derived: sum of 3 quarters · filed 2024-03-15 | -$15.92M 10-K · filed 2024-03-15 | ||||
| 2022-09-30 | -$4.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$15.57M derived: sum of 2 quarters · filed 2023-11-14 | -$21.21M 10-Q · filed 2023-11-14 | -$12.04M derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | -$10.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$16.39M 10-Q · filed 2023-08-10 | -$7.22M derived: sum of 3 quarters · filed 2023-08-10 | -$14.17M derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | -$5.63M 10-Q · filed 2023-05-11 | $3.54M derived: sum of 2 quarters · filed 2023-05-11 | -$3.41M derived: sum of 3 quarters · filed 2023-05-11 | -$8.53M derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | $9.17M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $2.22M derived: sum of 2 quarters · filed 2023-03-14 | -$2.89M derived: sum of 3 quarters · filed 2023-03-14 | -$7.49M 10-K · filed 2023-03-14 | ||||
| 2021-09-30 | -$6.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$12.06M derived: sum of 2 quarters · filed 2022-11-10 | -$16.66M 10-Q · filed 2022-11-10 | -$20.45M derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2021-06-30 | -$5.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$9.71M 10-Q · filed 2022-08-11 | -$13.50M derived: sum of 3 quarters · filed 2022-08-11 | -$18.59M derived: sum of 4 quarters · filed 2022-08-11 | ||||
| 2021-03-31 | -$4.59M 10-Q · filed 2022-05-12 | -$8.38M derived: sum of 2 quarters · filed 2022-05-12 | -$13.47M derived: sum of 3 quarters · filed 2022-05-12 | -$15.95M derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | -$3.79M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | -$8.88M derived: sum of 2 quarters · filed 2022-03-10 | -$11.35M derived: sum of 3 quarters · filed 2022-03-10 | -$15.56M 10-K · filed 2022-03-10 | -$15.56M 10-K · filed 2021-03-11 | |||
| 2020-09-30 | -$5.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$7.57M derived: sum of 2 quarters · filed 2021-11-10 | -$11.78M 10-Q · filed 2021-11-10 | -$11.78M 10-Q · filed 2020-11-05 | -$19.15M derived: sum of 4 quarters · filed 2021-11-10 | |||
| 2020-06-30 | -$2.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | -$6.68M 10-Q · filed 2021-08-11 | -$6.68M 10-Q · filed 2020-08-06 | -$14.06M derived: sum of 3 quarters · filed 2021-08-11 | -$17.21M derived: sum of 4 quarters · filed 2021-08-11 | |||
| 2020-03-31 | -$4.21M 10-Q · filed 2021-05-11 | -$4.21M 10-Q · filed 2020-05-07 | -$11.59M derived: sum of 2 quarters · filed 2021-05-11 | -$14.74M derived: sum of 3 quarters · filed 2021-05-11 | -$17.16M derived: sum of 4 quarters · filed 2021-05-11 | |||
| 2019-12-31 | -$7.38M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | -$10.53M derived: sum of 2 quarters · filed 2021-03-11 | -$12.95M derived: sum of 3 quarters · filed 2021-03-11 | $85.74M 10-K · filed 2021-03-11 | ||||
| 2019-09-30 | -$3.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$5.57M derived: sum of 2 quarters · filed 2020-11-05 | $93.12M 10-Q · filed 2020-11-05 | |||||
| 2019-06-30 | -$2.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $96.27M 10-Q · filed 2020-08-06 | ||||||
| 2019-03-31 | $98.69M 10-Q · filed 2020-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |